Chemoinformaics analysis of (R)-4-Hydroxy-2,6,6-trimethyl-2-cyclohexene-1-one
| Molecular Weight | 154.209 | nRot | 0 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 8 |
| Exact Molecular Weight | 154.099 | nRing | 1 |
| Solubility: LogS | -0.67 | nHRing | 0 |
| Solubility: LogP | 0.921 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.9691 |
| nHD | 1 | BPOL | 14.9129 |
| QED | 0.531 |
| Synth | 3.57 |
| Natural Product Likeliness | 1.54 |
| NR-PPAR-gamma | 0.782 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.04 |
| Pgp-sub | 0.003 |
| HIA | 0.007 |
| CACO-2 | -4.562 |
| MDCK | 0.0000334 |
| BBB | 0.864 |
| PPB | 0.44619 |
| VDSS | 0.714 |
| FU | 0.708918 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.595 |
| CYP2c19-inh | 0.095 |
| CYP2c19-sub | 0.844 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.726 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.742 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.26 |
| CL | 10.192 |
| T12 | 0.854 |
| hERG | 0.006 |
| Ames | 0.247 |
| ROA | 0.117 |
| SkinSen | 0.096 |
| Carcinogencity | 0.189 |
| EI | 0.539 |
| Respiratory | 0.482 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.92804 |